Method for amplifying quinolone-resistance-determining-regions and identifying polymorphic variants thereof

• US 20020072058A1
• Filed: 03/23/2001
• Published: 06/13/2002
• Est. Priority Date: 03/24/2000
• Status: Abandoned Application

• Current Assignee: LG Life Sciences Limited (LG Corporation)
• Original Assignee: LG Life Sciences Limited (LG Corporation)
• Inventors: Wilding, Edwina I., Voelker, Leroy L.
• Application Number:
  US09/815,498
• Publication Number:
  US 20020072058A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C12Q 1/689 for bacteria
• CPC Class Codes: C12Q 2600/156 Polymorphic or mutational markers
• CPC Class Codes: Y02A 50/30 Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The present invention provides a novel method for obtaining regions of bacterial polynucleotide sequence associated with quinolone resistance. In particular, methods for detecting Quinolone Resistance-Determining Regions (QRDRs) across a broad phylogenetic range in prokaryotes are disclosed.

Claims

1. A method for amplifying a polynucleotide sequence of a QRDR comprising the steps of:

(a) providing a composition comprising a degenerate forward primer of the invention and degenerate reverse primer of the invention, and a sample suspected to have a polynucleotide comprising a QRDR; and

(b) amplifying a QRDR.

2. The method of claim 1 wherein a primer is labeled.

3. The method of claim 1 wherein a primer is between 10 and 30 nucleotides in length.

4. The method of claim 1 whereby the amplifying step comprises PCR.

5. The method of claim 1 whereby the amplifying step (b) comprises between about 40 to 50 reaction cycles.

11. The method of claim 1 or 6 wherein said QRDR is amplified from a member of the genus selected from the group consisting of Psuedomonas, Enterococcus, Staphylococcus, Escherichia, Acinetobacter, Citrobacter, Corynebacterium, Enterobacter, Klebsiella, Morganella, Micrococcus, Proteus, Providenica, Serratia, and Stenotrophomonas.

12. The method of claim 1 or 6 wherein said QRDR is amplified from a member of the species selected from the group consisting of Psuedomonas aeruginosa, Enterococcus faecalis, Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli, Acinetobacter baumanii, Acinetobacter calcoaceticus, Citrobacter freundii, Corynebacterium xerosis, Enterobacter aerogenes, Enterobacter cloacae, Kleibsiella pneumoniae, Kleibsiella oxytoca, Morganella morganii, Micrococcus luteus, Proteus mirabilis, Providenica spp., Serratia marcessens, and Stenotrophomonas maltophilia.

13. The method of claim 1 or 6 wherein said QRDR is from a gene selected from the group consisting of gyrA, gyrB, parC, and parE.

15. A composition comprising the primer of claim 14.

6. A method for identifying a polymorphic polynucleotide sequence of a QRDR comprising the steps of:

(a) providing a composition comprising a degenerate forward primer of the invention and/or and a degenerate reverse primer of the invention, and a sample suspected to have a polynucleotide comprising a QRDR region;

(b) amplifying a QRDR to obtain an amplified product;

(c) sequencing said amplified product to obtain a first polynucleotide sequence; and

(d) comparing said first polynucleotide sequence with a second polynucleotide sequence of an amplified product made using said degenerate forward primer primer of the invention and said degenerate reverse primer primer of the invention to identify sequence differences between said first polynucleotide sequence and said second polynucleotide sequence.

7. The method of claim 6 wherein a primer is labeled.

8. The method of claim 6 wherein a primer is between 10 and 30 nucleotides in length.

9. The method of claim 6 whereby the an amplifying step comprises PCR.

10. The method of claim 6 whereby the amplifying step (b) comprises between about 40 to 50 reaction cycles.

14. A polynucleotide selected from the group consisting of:

16. A method for identifying a polynucleotide sequence of a QRDR comprising the steps of:

(a) providing a composition comprising a degenerate primer of the present invention suitable for use in hybridizations, which comprises a solid surface on which is immobilized at pre-defined regions thereon a plurality of defined oligonucleotide/polynucleotide sequences for hybridization; and

(b) identifying, sequencing, and characterizing genes which are implicated in disease, infection, or development and the use of such identified genes and the proteins encoded thereby in diagnosis, prognosis, therapy and drug discovery.